206650 Stock Chart & Stats
₩7930.00
₩490.00(6.59%)
―
--
Day’s Range― - ―
52-Week Range₩6,950.00 - ₩17,700.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)213.65K
Market Cap
₩291.45B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)9.9
Beta0.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding36,752,308
10 Day Avg. Volume125,353
30 Day Avg. Volume213,653
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1,541,850.22
Revenue Forecast (FY)₩10.00T>
206650 FAQ
What was EuBiologics Co., Ltd.’s price range in the past 12 months?
EuBiologics Co., Ltd. lowest stock price was ₩6950.00 and its highest was ₩17700.00 in the past 12 months.
What is EuBiologics Co., Ltd.’s market cap?
EuBiologics Co., Ltd.’s market cap is ₩291.45B.
When is EuBiologics Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were EuBiologics Co., Ltd.’s earnings last quarter?
EuBiologics Co., Ltd. released its earnings results on May 14, 2026. The company reported ₩99.79 earnings per share for the quarter, beating the consensus estimate of N/A by ₩99.79.
Is EuBiologics Co., Ltd. overvalued?
According to Wall Street analysts EuBiologics Co., Ltd.’s price is currently Undervalued.
Does EuBiologics Co., Ltd. pay dividends?
EuBiologics Co., Ltd. does not currently pay dividends.
What is EuBiologics Co., Ltd.’s EPS estimate?
EuBiologics Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EuBiologics Co., Ltd. have?
EuBiologics Co., Ltd. has 36,752,308 shares outstanding.
What happened to EuBiologics Co., Ltd.’s price movement after its last earnings report?
EuBiologics Co., Ltd. reported an EPS of ₩99.79 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.765%.
Which hedge fund is a major shareholder of EuBiologics Co., Ltd.?
Currently, no hedge funds are holding shares in KR:206650
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Samyang Biopharm Corporation
―
Hans Biomed Corp
―
SillaJen, Inc.
―
HUONS CO., LTD
―
IMBiologics Corp.
―